Generates revenue by selling prescription medical cannabis flowers and oils, produced under subcontract, to distributors and licensed pharmacies that dispense them to patients.
Geographic Exposure
IsraelN/A
Revenue Drivers
Medical cannabis product sales
Sells prescription cannabis flowers and oils produced under subcontract
CORE100%
End Markets
Fette Pharma
Kamifal Ltd
Super-Pharm
Licensed pharmacies
Prescription-holding patients
Specializations
Proprietary cannabis genetics and unique strainsLicensed Tikun Olam brand and strain rightsIMC medical-grade regulatory licensing across the production chainTransition to a constructive licence without handling the substanceSubcontracted cultivation and productionDirect distribution to licensed pharmacies+1 more
